AMENDMENT NO. 2 TO WARRANT TO PURCHASE STOCKPurchase Stock • December 29th, 2016 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment No. 2 to Warrant to Purchase Stock (this “Amendment”), dated as of December 27, 2016, is being entered into between Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and IMMY Funding LLC, a Delaware limited liability company (“IMMY Funding”). Capitalized terms used in this Amendment without definition have the respective definitions ascribed to them in the Existing Warrant (as defined below).
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • December 29th, 2016 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of December 27, 2016 (the “Amendment Effective Date”), is made among Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Borrower”), the undersigned Subsidiaries of the Borrower, in their capacities as Guarantors, IMMY Funding LLC, a Delaware limited liability company (“IMMY Funding LLC”), in its capacity as collateral agent (in such capacity, “Collateral Agent”) and the Lenders listed on Schedule 1.1 (as amended herein) of the Loan and Security Agreement (as defined below) or otherwise a party hereto from time to time including IMMY Funding LLC in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”).
EXCHANGE AND DISCHARGE AGREEMENTExchange and Discharge Agreement • December 29th, 2016 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations
This Exchange and Discharge Agreement (this “Agreement”), dated as of December 27, 2016, is being entered into between Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and IMMY Funding LLC, a Delaware limited liability company (“IMMY Funding”).
